EN DE
STOCK COMPARISON

Asker Healthcare vs McKesson: Fair Value & Quality

Both stocks run through our valuation models. Here is how Asker Healthcare (ASKER) and McKesson (MCK) compare, as of Sep 5, 2026.

As of Sep 5, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Asker Healthcare trades at SEK 73.00 versus a fair value of SEK 28.26 (-61%), while McKesson trades at $921 versus $819 (-11%).
Asker Healthcare
ASKER.ST · SEK · Health Care
-61%
upside to fair value
overvalued
PriceSEK 73.00
Fair ValueSEK 28.26
Quality52/100
McKesson
MCK · USD · Health Care
-11%
upside to fair value
overvalued
Price$921
Fair Value$819
Quality67/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Asker HealthcareMcKesson
Valuation
45.5×P/E (TTM)21.0×
1.76×P/S (TTM)0.23×
4.64×P/B—
19.9×EV/EBITDA13.9×
—PEG1.57×
−61.3%Fair value upside−11.1%
0.5%Dividend yield0.3%
SEK 0.39Dividend per share$3.17
Profitability
7%Operating margin2%
0.94×EBIT margin trend (5Y)1.60×
9%Return on equity—
5%Return on assets5%
Growth
13%Revenue growth (YoY)6%
12.7%Avg. growth/yr (3Y)13.4%
—Avg. growth/yr (5Y)11.1%
+2.3%Value creation/yr+44.8%
Balance & size
1.8×Interest coverage (EBIT/interest)26.1×
0.64×Debt / equity—
$3BMarket cap$94B
healthyGrowth qualityhealthy

McKesson leads: 2 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Asker Healthcareof which business quality 53 · market factors 36 McKessonof which business quality 65 · market factors 70
ProfitabilityMargins and returns on capital today
48
49
Quality GrowthAre margins and returns improving?
40
65
CashflowEarnings quality: real cash, not paper profit
51
47
Fin. StrengthBalance sheet, leverage, solvency risk
51
72
InvestmentDisciplined investing over empire-building
34
76
Low VolatilityCalm price path (market factor)
49
83
MomentumPrice trend over the last 3–12 months (market factor)
40
60
52W MomentumDistance to the 52-week high (market factor)
15
75
Net IssuanceBuybacks instead of dilution
98
100

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyAsker HealthcarePrice SEK 73.00McKessonPrice $921
DCF Models-50%below the priceSEK 36.54+4%close to the price$955
Earnings-Based-77%below the priceSEK 16.71-52%below the price$444
Dividend Discountn/a-94%below the price$57.26
Multiples-63%below the priceSEK 26.90-8%close to the price$848
Asset-Based-84%below the priceSEK 11.47n/a
Growth DCF-51%below the priceSEK 35.620%close to the price$922
Economic Profit-79%below the priceSEK 15.59-46%below the price$497
Growth Earnings-64%below the priceSEK 26.28-23%below the price$708
Minimum-84%below the priceSEK 11.47-94%below the price$57.26
Maximum-50%below the priceSEK 36.54+4%close to the price$955
Median-64%below the priceSEK 26.28-23%below the price$708
Geometric mean-69%below the priceSEK 22.31-47%below the price$489

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Asker Healthcare: 24 of 24 models see the stock below the current price.

McKesson: 15 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Asker Healthcare
Bear SEK 16.49Fair Value SEK 28.26Bull SEK 35.32
SEK 73.00 = current price (white tick)
McKesson
Bear $605Fair Value $819Bull $1,034
$921 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Asker Healthcare · Health Care

Quality score52 · below median
Fair value upside-61% · below median

McKesson · Health Care

Quality score67 · Top 25%
Fair value upside-11% · above median

Bottom line

As of Sep 5, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Asker Healthcare trades at SEK 73.00 versus a fair value of SEK 28.26 (-61%), while McKesson trades at $921 versus $819 (-11%).

McKesson has the higher quality score (67/100).

See the full analysis →
Asker Healthcare · McKesson

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Asker Healthcare

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupMerck & Company vs UnitedHealth Group

Related to McKesson

AstraZeneca vs UnitedHealth GroupThermo Fisher Scientific vs UnitedHealth GroupAmgen vs UnitedHealth GroupAbbott Laboratories vs UnitedHealth Group
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.